Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Gandhi, L.; Aufiero Ramirez, K.; Schwarzenberger, P.; Ricciardi, T.; Macri, M. J.; Ryan, A.; More, S.; Venhaus, R. R. |
| Abstract Title: | Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 486s |
| Language: | English |
| ACCESSION: | WOS:000442916008011 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS9107 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS9107 -- Source: Wos |
